Contracts › 75F40125F19002
75F40125F19002: Center for Biologics Evaluation and Research (CBER) Requirement for Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3)
Awarded to Cvs Healthspire Payor & Life Sciences Llc by Food and Drug Administration (FDA).
$5.5Mobligated
$5.5Mpotential value
29 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40125F19002 |
|---|---|
| Vehicle | 75F40124D00042 |
| Awardee | Cvs Healthspire Payor & Life Sciences Llc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services |
| PSC | B537 Special Studies/Analysis- Medical/Health |
| Place of performance | CT |
| Offers received | 4 |
| Period of performance | 29 September 2025 to 29 September 2026 |
| Potential end | 29 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 518210 contracts · All expiring contracts · USASpending record